ClinicalTrials.gg
RecruitingNCT06942455SIESTAUpdated Sep 4, 2026

A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children

An interventional study of SIESTA and Sleep education and health education control in Sleep, Sleep Quality and Intervention Study, sponsored by Rhode Island Hospital. Recruiting at 2 sites in 2 countries. Open to participants aged 11 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Rhode Island Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
11 Years to 13 Years
Sex
All
01

Study summary

The main goal of this study is to evaluate the "SIESTA" intervention, a culturally and contextually tailored sleep hygiene intervention that has the potential to exert greater improvements in sleep hygiene and sleep outcomes for group that may be more vulnerable to poor sleep health.

The main question is: do SIESTA participants have improved sleep outcomes, sleep hygiene behaviors and less sleep-related impairment compared to Control Group participants?

Participants randomized to the SIESTA intervention will:

  1. Attend 4 remotely administered group sleep hygiene education sessions
  2. Complete along with a parent/guardian, two individualized sessions administered by a SIESTA intervention facilitator
  3. Complete study survey at baseline, end of treatment, and at 4, 8 and 12 months post-intervention.
  4. Wear electronic sleep watches (actigraphy) throughout the protocol to objectively measure sleep duration and quality.

Participants randomized to the Child Health Control condition will:

  1. Attend 4 remotely administered group sessions covering general health topics
  2. Complete along with a parent/guardian, two individualized sessions administered by a SIESTA intervention facilitator
  3. Complete study survey at baseline, end of treatment, and at 4, 8 and 12 months post-intervention.
  4. Wear electronic sleep watches (actigraphy) throughout the protocol to objectively measure sleep duration and quality.

A secondary goal of the study is to conduct a process evaluation to prepare for future larger scale use of the intervention in other urban school settings. This will entail assessing Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) of the program through several methods, such as by conducting in-depth interviews with research participants and their parents/guardians, as well as school staff and by looking at rates of participation in the program.

Read the detailed description

Sleep is essential for optimal health and development. Poor sleep is associated with impaired functioning and academic performance, and worse health outcomes in children. Latino children are disproportionately present in urban settings, and due to their exposure to higher levels of urban and cultural stressors, are at greater risk for poor sleep hygiene and quality.

SIESTA (School Intervention to Enhance Latino Students' Time Asleep) is a novel sleep hygiene intervention for improving sleep hygiene and sleep duration in urban Latino middle schoolers in two geographic areas with a high proportion of urban Latino children at increased risk for poor sleep health: Providence, Rhode Island, and San Juan, Puerto Rico.

SIESTA involves 4 group sessions administered in school to Latino middle schoolers (6th-8th grade) and two child-caregiver sessions administered remotely by a bilingual (English/Spanish) trained facilitator from the community.

The goal of this project is to administer a two-site hybrid type 1 effectiveness-implementation design to evaluate SIESTA's effects on a larger-scale- for addressing Latino middle schooler's sleep health, while also assessing implementation determinants.

The first aim of the study is to evaluate SIESTA through a large-scale RCT with urban middle school students in Providence, RI and San Juan, Puerto Rico. The researchers will enroll 150 Latino children per site (N=300), and randomly assign them either to the SIESTA intervention, or to the Sleep Education plus Child Health attention-control condition (9 groups of each of the two conditions, per site; 8-9 students per group). Treatment effects on primary sleep outcomes will be evaluated, including sleep duration, efficiency and sleep onset latency. Secondary sleep outcomes will include sleep hygiene behaviors, the sleep environment, and sleep-related disturbances and impairment. Assessments will occur prior to, immediately following, and at 4, 8, and 12 months after the intervention.

Each participant will be active in the protocol over approximately 14 months, during which it is hypothesized that SIESTA participants will have improved sleep outcomes, sleep hygiene behaviors and less sleep-related impairment relative to Controls.

The second study aim is to identify implementation determinants and preliminary implementation outcomes of SIESTA to prepare for future large-scale implementation in other urban school settings. A mixed methods process evaluation will be implemented, with input from community partners using the RE-AIM framework throughout and following administration of the RCT.

SIESTA has the potential to improve sleep outcomes in urban Latino children and their daytime functioning, and to address a critical gap of the need for tailored and effective sleep hygiene interventions for children at greater risk for poor sleep health.

02

Conditions studied

  • Sleep
  • Sleep Quality
  • Intervention Study
  • Ethnic Minority

Keywords

  • pediatric sleep intervention
  • sleep hygiene intervention
  • intervention determinants
  • sleep outcomes
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 300 is above the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Rhode Island Hospital is the lead sponsor of 191 studies on the registry; 36 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children must be middle schoolers between 11-13 years old, live and go to school in one of the targeted school districts and sleep no more than 9 hours on an average night

Exclusion criteria

Exclusion Criteria:

  • Children are not eligible to take part in the study if they have a medical, psychiatric, or developmental condition and/or are taking medicine for any condition that might affect their ability to and comfort with taking part in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    SIESTA

    The SIESTA Intervention includes 4, 60-minute group remote sessions by a trained facilitator, and 2, 90-minute family sessions in their home 1 week after group Sessions 1 and 4. SIESTA incorporates key sleep hygiene principles and strategies critical to optimal sleep health in middle schoolers and tailored to urban Latino children's cultural background and urban setting. Areas of focus include the importance of adequate sleep duration, principles and strategies to enhance sleep hygiene, and characteristics of healthy sleep environments, and were developed with targeted goals. After intervention group Session 1, daily sleep questions about the child participant are completed, including key sleep parameters (bedtime, rise time, night awakenings) and sleep hygiene behaviors (daytime naps, electronics, caffeine use) via Qualtrics. Responses are summarized and presented pictorially in caregiver-child sessions to facilitate developing sleep goals for the youth and assess their progress.

    Behavioral: SIESTA

  • Other
    Sleep Education plus Child Health attention control

    A facilitator from the community will deliver this attention control condition, which consists of the same number of sessions as SIESTA but will focus only on basic sleep hygiene education plus general child health topics (e.g., nutrition, physical activity, safety). It is expected that this will exert limited treatment effects on sleep hygiene, because it does not 1) involve effective behavioral approaches for this age group, or 2) include content tailored for urban Latinos.

    Behavioral: Sleep education and health education control

Interventions

  • BehavioralSIESTA

    Active condition

  • BehavioralSleep education and health education control

    Attention Control

06

What researchers measure

Primary outcomes

  1. Sleep Duration

    Sleep Duration through actigraphy will be calculated through Time in Bed (TIB) scores. A daily diary will document sleep events (e.g., bedtime) to score actigraphic data . Children will wear the actigraph Motion Logger device for 1-2 weeks at each time point. Data will be compared to data in a family-report daily diary using standard procedures.

    Time frame: Sleep duration will be assessed for 1-2 weeks at baseline, immediately after the intervention ("end of treatment") and at follow ups at 4, 8, and 12 months post intervention/control.

  2. Sleep Efficiency/Quality

    Sleep efficiency will be estimated via actigraphy and will be calculated through % epochs of sleep between sleep start and sleep end.

    Time frame: Sleep efficiency will be assessed for 1-2 weeks at baseline, end of treatment and at each 4, 8, and 12 months post intervention/control.

Secondary outcomes

  1. Sleep Disturbance and Sleep-related Impairment

    Sleep disturbance and sleep-related impairment will be assessed by caregiver and child report by the Patient-Reported Outcomes Measurement Information System (PROMIS™) measures (Yu et al., 2011). Participants will be asked to report on the previous week. Raw scores are converted to T-scores (Mean=50, SD=10). Higher scores indicate more of the concept being measured, hence higher scores on Sleep Disturbance and Sleep Impairment indicate less optimal status on these domains, while scores lower than T=50 indicate better functioning (less sleep disturbance and sleep impairment).

    Time frame: Sleep Disturbance and Sleep-related Impairment measures will be collected on each child at each of the of the 5 research assessment time points: enrollment/baseline, immediately after the intervention, and at the 4, 8 and 12 month follow up visits.

07

Study locations

1 of 2 sites recruiting
  • Rhode Island Hospital
    Providence, Rhode Island 02903, United States
    Recruiting
    • Sheryl J Kopel, MSc · Contactsjkopel@brownhealth.org · +1-401-444-7217
    • Daphne Koinis-Mitchell, PhD · Principal investigator
    • Julie Boergers, PhD · Sub investigator
  • Centro Medico
    San Juan, Puerto Rico, Puerto Rico
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The final datasets will include individual participant survey data, diary data, and aggregated daily-level actigraphy data. We will share cleaned and de-identified individual-participant level data where all HIPAA identifiers have been removed. The rationale for sharing only cleaned data is to facilitate data reuse. All data will be made available through a user agreement. A README file and data dictionary will be generated and deposited into a repository along with all shared datasets. Documentation will include a description of the study design and methods, survey measures, data acquisition devices (actigraphy), and any other tools (e.g., software, databases, services) used in the study or in processing the data. The data dictionary will describe all variables in the dataset. The finalized SIESTA and Control Group Training manuals for group facilitators, and the SIESTA and Control Group Intervention manuals will be available in English and Spanish.

Supporting information: Study protocol

Time frame: Outcomes data related to the primary specific aims will be available at the time of publication; all other generated data will be shared when data processing is complete. All study data will be stored in the repository for at least 5 years.

Access criteria: The National Sleep Research Resource (NSRR) funded by NHLBI is a potentially suitable repository. The MPIs will review this and other options during study implementation and will consult the data management experts at their institution and collaborators with relevant expertise. The final decision for repository will be made by the MPIs with consultation on best practices for data preservation for this study from these resources/ colleagues.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06942455
Responsible party
Sponsor
First posted
Apr 24, 2025
Start date
Jun 25, 2025
Primary completion
Mar 31, 2029 (estimated)
Completion
Mar 31, 2029 (estimated)
Last update
Sep 4, 2026

Study contacts

Sheryl J Kopel, MSc
Contact
Sheryl_Kopel@brown.edu
+1-401-444-7217
Daphne Koinis-Mitchell, PhD
Contact
Daphne_Koinis-Mitchell@brown.edu
+1-401-793-8632
Daphne Koinis-Mitchell, PhD
principal investigator · Alpert Medical School of Brown University
Ligia Chavez, PhD
principal investigator · University of Puerto Rico Medical Sciences Campus

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion